![Paul van Slyke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul van Slyke formerly worked at Vasomune Therapeutics, Inc., as Chief Scientific Officer, Sairiyo Therapeutics, Inc., as Chief Scientific Officer, and Pharmadrug, Inc., as Chief Scientific Officer from 2021 to 2023.
Dr. van Slyke received his doctorate degree from the University of Toronto.
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMADRUG INC. | Directeur Technique/Scientifique/R&D | 01/05/2023 |
Sairiyo Therapeutics, Inc.
 Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures psychedelics drugs for treatment of non-neuropsychiatric conditions | Directeur Technique/Scientifique/R&D | - |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops medications for treatment of diseases associated with vascular dysfunction | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops medications for treatment of diseases associated with vascular dysfunction | Health Technology |
Pharmadrug, Inc.
 Pharmadrug, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development of cannabis-infused edible products and oil extracts | Health Technology |
Sairiyo Therapeutics, Inc.
Sairiyo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures psychedelics drugs for treatment of non-neuropsychiatric conditions | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
